D
Context Therapeutics Inc. CNTX
$0.8595 -$0.0134-1.54% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 1.93M 2.07M 1.79M 1.88M 1.70M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 9.76M 5.53M 4.31M 18.70M 3.09M
Operating Income -9.76M -5.53M -4.31M -18.70M -3.09M
Income Before Tax -8.83M -4.58M -3.34M -17.46M -2.25M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -8.83M -4.58M -3.34M -17.46M -2.25M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -8.83M -4.58M -3.34M -17.46M -2.25M
EBIT -9.76M -5.53M -4.31M -18.70M -3.09M
EBITDA -9.75M -5.53M -4.31M -18.70M -3.09M
EPS Basic -0.09 -0.05 -0.04 -0.22 -0.04
Normalized Basic EPS -0.06 -0.03 -0.03 -0.14 -0.03
EPS Diluted -0.09 -0.05 -0.08 -0.22 -0.04
Normalized Diluted EPS -0.06 -0.03 -0.03 -0.14 -0.03
Average Basic Shares Outstanding 95.19M 95.19M 81.93M 80.48M 54.96M
Average Diluted Shares Outstanding 95.19M 95.19M 81.93M 80.48M 54.96M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --